UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3796) 3796
Book Chapter (35) 35
Magazine Article (11) 11
Newspaper Article (4) 4
Book / eBook (1) 1
Book Review (1) 1
Dissertation (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2867) 2867
life sciences & biomedicine (2802) 2802
humans (2768) 2768
male (1913) 1913
female (1398) 1398
adrenergic uptake inhibitors - therapeutic use (1339) 1339
animals (1194) 1194
pharmacology & pharmacy (1165) 1165
biological and medical sciences (1140) 1140
medical sciences (1060) 1060
psychiatry (923) 923
neurosciences & neurology (823) 823
adult (808) 808
neurosciences (701) 701
middle aged (699) 699
pharmacology. drug treatments (683) 683
treatment outcome (670) 670
serotonin uptake inhibitors - therapeutic use (664) 664
rats (571) 571
adrenergic beta-antagonists - therapeutic use (539) 539
attention deficit disorder with hyperactivity - drug therapy (516) 516
adrenergic uptake inhibitors - pharmacology (503) 503
adolescent (465) 465
psychology. psychoanalysis. psychiatry (452) 452
atomoxetine hydrochloride (451) 451
child (446) 446
adrenergic uptake inhibitors - adverse effects (444) 444
aged (444) 444
psychopharmacology (415) 415
drug therapy (411) 411
clinical neurology (409) 409
neuropharmacology (409) 409
dose-response relationship, drug (380) 380
propylamines - therapeutic use (379) 379
double-blind method (354) 354
cardiovascular system & cardiology (325) 325
antidepressive agents - therapeutic use (323) 323
abridged index medicus (300) 300
cardiac & cardiovascular systems (295) 295
medicine & public health (281) 281
atomoxetine (274) 274
psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (272) 272
antidepressants (267) 267
heart failure (263) 263
care and treatment (257) 257
mice (256) 256
time factors (254) 254
adrenergic uptake inhibitors - administration & dosage (252) 252
attention deficit hyperactivity disorder (247) 247
attention-deficit hyperactivity disorder (246) 246
research (245) 245
serotonin uptake inhibitors - pharmacology (242) 242
rats, sprague-dawley (240) 240
neurology (226) 226
psychopathology. psychiatry (225) 225
analysis (221) 221
central nervous system stimulants - therapeutic use (220) 220
pharmacology/toxicology (216) 216
depressive disorder - drug therapy (212) 212
pediatrics (210) 210
norepinephrine (202) 202
adrenergic receptors (201) 201
depression (198) 198
drug therapy, combination (197) 197
norepinephrine - metabolism (197) 197
serotonin uptake inhibitors - adverse effects (195) 195
general & internal medicine (192) 192
heart failure - drug therapy (186) 186
duloxetine hydrochloride (185) 185
risk factors (185) 185
pharmacology (182) 182
rats, wistar (181) 181
psychology (180) 180
randomized controlled trials as topic (179) 179
noradrenaline (178) 178
adrenergic beta-antagonists - pharmacology (177) 177
clinical trials (176) 176
social sciences (176) 176
psychiatric status rating scales (172) 172
angiotensin-converting enzyme inhibitors - therapeutic use (169) 169
medicine, general & internal (169) 169
depressive disorder, major - drug therapy (168) 168
serotonin (168) 168
rodents (167) 167
biomedicine (165) 165
thiophenes - therapeutic use (164) 164
young adult (164) 164
drug interactions (163) 163
propylamines - adverse effects (163) 163
health aspects (162) 162
disease models, animal (161) 161
heart (160) 160
dopamine (158) 158
internal medicine (156) 156
antidepressive agents - pharmacology (155) 155
severity of illness index (151) 151
methylphenidate - therapeutic use (148) 148
cardiology (147) 147
fundamental and applied biological sciences. psychology (146) 146
pharmacotherapy (143) 143
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3724) 3724
German (49) 49
French (23) 23
Russian (21) 21
Spanish (19) 19
Japanese (17) 17
Danish (6) 6
Dutch (5) 5
Norwegian (5) 5
Italian (4) 4
Hungarian (3) 3
Portuguese (3) 3
Chinese (2) 2
Finnish (2) 2
Hebrew (2) 2
Polish (2) 2
Romanian (2) 2
Swedish (2) 2
Turkish (2) 2
Czech (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neurology, ISSN 0028-3878, 04/2012, Volume 78, Issue 16, pp. 1229 - 1236
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Biological and medical sciences | Medical sciences | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | Psychiatric Status Rating Scales - statistics & numerical data | Humans | Depressive Disorder - drug therapy | Male | Parkinson Disease - drug therapy | Paroxetine - therapeutic use | Paroxetine - adverse effects | Paroxetine - administration & dosage | Adult | Female | Severity of Illness Index | Adrenergic Uptake Inhibitors - adverse effects | Parkinson Disease - complications | Adrenergic Uptake Inhibitors - therapeutic use | Double-Blind Method | Drug Administration Schedule | Depressive Disorder - diagnosis | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Antidepressive Agents - therapeutic use | Venlafaxine Hydrochloride | Delayed-Action Preparations - adverse effects | Depressive Disorder - complications | Serotonin Uptake Inhibitors - administration & dosage | Adrenergic Uptake Inhibitors - administration & dosage | Cyclohexanols - therapeutic use | Delayed-Action Preparations - therapeutic use | Antidepressive Agents - administration & dosage | Antidepressive Agents - adverse effects | Cyclohexanols - administration & dosage | Parkinson's disease | paroxetine | Neurodegenerative diseases | Antidepressants | Classification | Clinical trials | Depression | Serotonin uptake inhibitors | Venlafaxine | Norepinephrine | Movement disorders | Index Medicus | Abridged Index Medicus | 165 | 239 | 321
Journal Article
Pharmacology & therapeutics (Oxford), ISSN 0163-7258, 05/2006, Volume 110, Issue 2, pp. 135 - 370
Antidepressant | Multi-target | SSRI | Mood | Network theory | Depression | Co-morbidity | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Depressive Disorder, Major - etiology | Cyclohexanols - adverse effects | Dopamine Uptake Inhibitors - adverse effects | Depressive Disorder, Major - metabolism | Humans | Dopamine Uptake Inhibitors - therapeutic use | Nerve Net - drug effects | Drug Delivery Systems | Brain - metabolism | Drug Design | Neurons - metabolism | Drug Therapy, Combination | Neurons - drug effects | Dopamine - metabolism | Morpholines - adverse effects | Morpholines - therapeutic use | Bupropion - therapeutic use | Depressive Disorder, Major - drug therapy | Adrenergic Uptake Inhibitors - adverse effects | Antidepressive Agents - classification | Adrenergic Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Clinical Trials as Topic | Antidepressive Agents - therapeutic use | Brain - drug effects | Venlafaxine Hydrochloride | Animals | Norepinephrine - metabolism | Serotonin - metabolism | Nerve Net - metabolism | Cyclohexanols - therapeutic use | Bupropion - pharmacology | Antidepressive Agents - adverse effects | Nitrogen oxide | Drugs | Neuropeptide Y | Care and treatment | Monoamine oxidase | Corticosteroids | Neurons | Glycogen | Depression, Mental | Development and progression | Serotonin uptake inhibitors | Peptide hormones | Methyl aspartate | Synthesis | Workplace multiculturalism | GABA | Drug therapy, Combination | Health aspects | Noradrenaline | Index Medicus
Journal Article